Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT06987461
Recruiting Observational

Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease

NCT06987461 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier Intercommunal Creteil
Phase
Observational
Started
2025-01-06
Last updated
2025-05-23

Condition(s) studied

Bronchial Dilatation DiseaseBronchectasie

Study summary

This is a medical record data collection study. The goal of this non-interventional and retrospective study is to describe the characteristics of the population currently being monitored for bronchial dilatation who have been treated with long-term NIV. This is a study based on data from medical records.

The assessment criteria will be :

* Epidemiological characteristics of the population with bronchial dilatation on long-term NIV
* Reasons for initiation of NIV
* NIV adjustment methods

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients over 18 years * Predominant diagnosis of bronchiectatic disease, excluding cystic fibrosis, confirmed by computed tomography * Introduction of long-term NIV at a given point in the patient's care Exclusion Criteria: * Patient's opposition to participating in this study * Cystic fibrosis * Predominant diagnosis of COPD or asthma, traction bronchiectasis, bronchiectasis resulting from focal endobronchial lesion, sarcoidosis or active allergic bronchopulmonary aspergillosis.

Primary outcome measure(s)

  • epidemiological characteristics of the population with bronchial dilation under long-term NIV — Through study completion, an average of 1 year
  • Reasons for placing under NIV — Through study completion, an average of 1 year
  • Non-invasive ventilation adjustment modalities — Through study completion, an average of 1 year

Trial sites (5)

FacilityCityRegionStatus
Centre Hospitalier Intercommunal de Créteil Créteil France Recruiting
Centre Hospitalier Universitaire Henri Mondor Créteil France Recruiting
Centre Hospitalier Universitaire de Dijon Dijon France Not Yet Recruiting
Centre Hospitalier Universitaire de Rennes Rennes France Not Yet Recruiting
Centre Hospitalier Universitaire Toulouse Toulouse France Not Yet Recruiting

More Centre Hospitalier Intercommunal Creteil trials in France

Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services Recruiting
Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults Recruiting
ANgiogenic Function at NOrmal TErm on Placenta Recruiting
Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease Recruiting
ENVIEANCILLAIRE: Efficacy of Nirsevimab in Children Hospitalised With RSV Bronchiolitis - A Subsidiary Study on the Immune Signature and Microbial Environment Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06987461 on ClinicalTrials.gov ↗ ← All trials in France